You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
完美醫療(01830.HK):收益上升至13.93億港元 建議末期及特別息合共每股17.3港仙
格隆匯 06-28 12:04

格隆匯6月28日丨完美醫療(01830.HK)發佈公吿,截至2024年3月31日止年度,收益上升0.3%至13.93億港元;扣除利息、税項以及物業、廠房及設備折舊前盈利下降4.4%至4.61億港元;公司權益持有人應占利潤(不計及香港政府補助)增加6.8%至3.16億港元;每股基本盈利維持25.1港仙;建議末期及特別股息分別為每股11.9港仙及5.4港仙,合共每股17.3港仙,年度股息為每股31.5港仙。年度派息比率為125.5%,集團連續九年保持100%及以上派息比率。

回顧年度,儘管消費放緩,集團仍然交出穩健的表現。集團實現銷售合約價格14.46億港元,按年減少0.3%。集團的收益按年增加0.3%至13.93億港元(2022╱23財政年度:13.89億港元),此乃受惠於消費動力回升及中國香港及中國內地新店的貢獻。於本年度,醫療美容業務繼續為集團的核心業務,按銷售合約價值計算貢獻約81.8%。每名醫療美容顧客的平均消費按年上升2.7%至28,784港元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account